|
|
||||||||
Original Articles |
Chlamydia pneumoniae is a frequently occurring respiratory pathogen affecting all age groups. It may cause 5-20% of community-acquired pneumonias in adults and children. The organism has also been implicated as an infectious trigger for asthma. Furthermore, new studies suggest that it may play a role in the pathogenesis of several chronic diseases including atherosclerosis. However, despite the growing significance of C. pneumoniae as a pathogen, progress is hampered by the lack of standardized diagnostic methods including serology and polymerase chain reaction. This makes it practically impossible for the practitioner to make a specific microbiological diagnosis. The lack of standardized methods has also had an adverse effect on treatment trials. The dependence on serology for diagnosis in treatment studies has generated some questionable results. Unless cultures are performed, microbiological efficacy cannot be assessed and it may never be possible to survey for or document the emergence of resistance.
This article has been cited by other articles:
![]() |
N. Miyashita, K. Ouchi, F. Kishi, M. Tabuchi, N. Tsumura, H. Bannai, S. Iwata, T. Tanaka, and M. Oka Rapid and Simple Diagnosis of Chlamydophila pneumoniae Pneumonia by an Immunochromatographic Test for Detection of Immunoglobulin M Antibodies Clin. Vaccine Immunol., July 1, 2008; 15(7): 1128 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Apfalter Chlamydia pneumoniae, Stroke, and Serological Associations: Anything Learned From the Atherosclerosis-Cardiovascular Literature or Do We Have to Start Over Again? Stroke, March 1, 2006; 37(3): 756 - 758. [Full Text] [PDF] |
||||
![]() |
A. J. Littman, L. A. Jackson, and T. L. Vaughan Chlamydia pneumoniae and Lung Cancer: Epidemiologic Evidence Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 773 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hermann, K. Gueinzius, A. Oehme, S. von Aulock, E. Straube, and T. Hartung Comparison of Quantitative and Semiquantitative Enzyme-Linked Immunosorbent Assays for Immunoglobulin G against Chlamydophila pneumoniae to a Microimmunofluorescence Test for Use with Patients with Respiratory Tract Infections J. Clin. Microbiol., June 1, 2004; 42(6): 2476 - 2479. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |